INDV (Indivior Pharmaceuticals) Change In Inventory: $12 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INDV Indivior Pharmaceuticals Inc INDV
69 GF Score
Price $40.54
GF Value $22.91
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Indivior Pharmaceuticals Change In Inventory?

Indivior Pharmaceuticals INDV -0.10% 69 Change In Inventory is $12 Mil as of Mar. 2026. GuruFocus rates INDV with a GF Score™ of 69/100 and a GF Value™ of $22.91 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Indivior Pharmaceuticals's change in inventory for the quarter that ended in Mar. 2026 was $-1 Mil. It means Indivior Pharmaceuticals's inventory increased by $1 Mil from Dec. 2025 to Mar. 2026 .

Indivior Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2025 was $18 Mil. It means Indivior Pharmaceuticals's inventory declined by $18 Mil from Dec. 2024 to Dec. 2025 .

Indivior Pharmaceuticals's Total Inventories for the quarter that ended in Mar. 2026 was $152 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Indivior Pharmaceuticals's Days Inventory for the quarter that ended in Mar. 2026 was 350.17.

Inventory Turnover measures how fast the company turns over its inventory within a year. Indivior Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.26.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Indivior Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.48.

Indivior Pharmaceuticals  (NAS:INDV) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Indivior Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=153.5/40*365 / 4
=350.17

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Indivior Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=40 / 153.5
=0.26

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Indivior Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=153.5 / 317
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior Pharmaceuticals Change In Inventory Related Terms

Indivior Pharmaceuticals Change In Inventory Historical Data

* Premium members only.

The historical data trend for Indivior Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior Pharmaceuticals Change In Inventory Chart

Indivior Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.00 -30.00 -6.00 -43.00 18.00

Indivior Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 17.00 -6.00 2.00 -1.00
INDV
69GF Score
Indivior Pharmaceuticals Inc INDV
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indivior Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $12 Mil mean?
Indivior Pharmaceuticals (INDV) has a Change In Inventory of $12 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Indivior Pharmaceuticals and its competitors.
Is Indivior Pharmaceuticals' Change In Inventory too high?
Indivior Pharmaceuticals' current Change In Inventory is $12 Mil. Overall, Indivior Pharmaceuticals has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Indivior Pharmaceuticals' Change In Inventory compare to KNSA and AMRX?
Indivior Pharmaceuticals' Change In Inventory of $12 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Indivior Pharmaceuticals and its competitors. Indivior Pharmaceuticals's current Change In Inventory is $12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indivior Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Indivior Pharmaceuticals (INDV) is currently considered Significantly Overvalued. The stock's GF Value™ is $22.91, compared to a current price of $40.54 — trading 77% above its estimated fair value. The current Change In Inventory is $12 Mil. Indivior Pharmaceuticals' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Indivior Pharmaceuticals (INDV), the current Change In Inventory is $12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indivior Pharmaceuticals (INDV) Overvalued in 2026?

Based on GuruFocus' analysis, Indivior Pharmaceuticals stock appears to be overvalued. The current stock price of $40.54 is trading 77% above its estimated GF Value™ of $22.91. GuruFocus considers Indivior Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for INDV:

  • Change In Inventory: $12 Mil
  • GF Value™: $22.91 vs. price of $40.54 (77% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the INDV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indivior Pharmaceuticals Business Description

Other Exchanges E7P:Germany
Address 10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
69GF Score

Get the complete analysis for INDV

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.54
Price
$22.91
GF Value